Literature DB >> 14747381

Beneficial Effects of Estrogens on Indices of Renal Damage in Uninephrectomized SHRsp Rats.

Marie-Luise Gross1, Marcin Adamczak, Thomas Rabe, Nevin Ali Harbi, Jan Krtil, Andreas Koch, Peter Hamar, Kerstin Amann, Eberhard Ritz.   

Abstract

Renal diseases tend to be less severe among premenopausal female patients, compared with male patients. Experimental data on the effects of estrogens on renal damage are controversial, and potential underlying mechanisms have not been fully clarified. Three-month-old, female, uninephrectomized (UNX), sham-operated or ovariectomized (OVX) SHRsp rats were left untreated or received either 17beta-estradiol 3-benzoate (25 micro g/d) or estriol (0.02 mg/d) daily. After 3 mo, indices of renal damage (glomerulosclerosis index and tubulointerstitial damage index) and glomerular geometric parameters were investigated. The expression of desmin, TGF-beta, endothelin-1, collagen IV, endothelial nitric oxide synthase, and estrogen receptors alpha and beta in the glomeruli and tubulointerstitium was immunohistochemically evaluated. Estradiol and estriol did not significantly affect kidney weights or BP. Estradiol and estriol caused significant reductions in albuminuria (vehicle-treated UNX/OVX animals, 25.4 +/- 8.52 mg/24 h; estradiol-treated UNX/OVX animals, 15.37 +/- 6.12 mg/24 h; estriol-treated UNX/OVX animals, 6.54 +/- 2.24 mg/24 h). The glomerulosclerosis index was significantly lower in estriol- and estradiol-treated animals (estradiol-treated UNX/OVX animals, 0.69 +/- 0.16; estriol-treated UNX/OVX animals, 0.21 +/- 0.12; P < 0.05), compared with vehicle-treated animals (1.46 +/- 0.09); the tubulointerstitial damage index exhibited a similar pattern. The mean glomerular volume was significantly less in estrogen-treated animals. UNX/OVX animals demonstrated significantly greater expression of TGF-beta and endothelin-1 in immunohistochemical, in situ hybridization, and reverse transcription-PCR assays. This increase was abrogated by estriol but not estradiol. Similarly, significantly higher glomerular and tubulointerstitial expression of proliferating cell nuclear antigen and collagen IV was observed in UNX/OVX animals, and expression was decreased by estriol but not estradiol. It was concluded that, in the UNX model of spontaneous renal damage, glomerular lesions and glomerular hypertrophy were reduced by estriol but less consistently by estradiol. In parallel, loss of podocytes, evidence of podocyte injury (i.e., desmin expression), and expression of mediator systems of glomerular damage were decreased, pointing to a major renoprotective action of estriol.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14747381     DOI: 10.1097/01.asn.0000105993.63023.d8

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  37 in total

1.  Effect of estrogen deficiency on the fixation of titanium implants in chronic kidney disease mice.

Authors:  S Zhang; Y Guo; H Zou; N Sun; D Zhao; W Liu; Y Dong; G Cheng; Q Yuan
Journal:  Osteoporos Int       Date:  2014-11-01       Impact factor: 4.507

2.  Differential effects of continuous and intermittent 17beta-estradiol replacement and tamoxifen therapy on the prevention of glomerulosclerosis: modulation of the mesangial cell phenotype in vivo.

Authors:  Michael Karl; Mariana Berho; Judith Pignac-Kobinger; Gary E Striker; Sharon J Elliot
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

3.  Antifibrotic effect of tamoxifen in a model of progressive renal disease.

Authors:  Humberto Dellê; José Roberto C Rocha; Rita C Cavaglieri; José Mauro Vieira; Denise M A C Malheiros; Irene L Noronha
Journal:  J Am Soc Nephrol       Date:  2011-11-03       Impact factor: 10.121

Review 4.  The influence of gender and sexual hormones on incidence and outcome of chronic kidney disease.

Authors:  Sebastian Kummer; Gero von Gersdorff; Markus J Kemper; Jun Oh
Journal:  Pediatr Nephrol       Date:  2011-07-16       Impact factor: 3.714

5.  Estrogen and raloxifene, a selective estrogen receptor modulator, ameliorate renal damage in db/db mice.

Authors:  Masami Chin; Motohide Isono; Keiji Isshiki; Shin-ichi Araki; Toshiro Sugimoto; Baoliang Guo; Haruhisa Sato; Masakazu Haneda; Atsunori Kashiwagi; Daisuke Koya
Journal:  Am J Pathol       Date:  2005-06       Impact factor: 4.307

Review 6.  Sex related differences in the pathogenesis of organ fibrosis.

Authors:  Alejandra Garate-Carrillo; Julisa Gonzalez; Guillermo Ceballos; Israel Ramirez-Sanchez; Francisco Villarreal
Journal:  Transl Res       Date:  2020-03-16       Impact factor: 7.012

7.  Transforming growth factor beta1-induced glomerulopathy is prevented by 17beta-estradiol supplementation.

Authors:  Camilla Birch Nielsen; Søren Krag; Ruth ØSterby; Allan Flyvbjerg; Jens Nyengaard; Axel Forman; Lise Wogensen
Journal:  Virchows Arch       Date:  2004-04-24       Impact factor: 4.064

8.  Impact of menopausal status on kidney adaptation after unilateral nephrectomy for kidney donation in women.

Authors:  Pierre-Yves Charles; Marion Vallet; Renaud De La Faille; Pierre Merville; Séverine Lagarde; Nicolas Grenier; Claire Lebely; Benoît Lepage; Julien Allard; Nassim Kamar; Ivan Tack
Journal:  J Nephrol       Date:  2021-06-01       Impact factor: 3.902

9.  Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats.

Authors:  Tadashi Okada; Toshifumi Sakaguchi; Ikuji Hatamura; Fumie Saji; Shigeo Negi; Haruhisa Otani; Yasuteru Muragaki; Hiroshi Kawachi; Takashi Shigematsu
Journal:  Clin Exp Nephrol       Date:  2009-05-19       Impact factor: 2.801

10.  Differential effects of 17beta-estradiol and of synthetic progestins on aldosterone-salt-induced kidney disease.

Authors:  Paula-Anahi Arias-Loza; Melanie Muehlfelder; Susan A Elmore; Robert Maronpot; Kai Hu; Hartmut Blode; Christa Hegele-Hartung; Karl Heinrich Fritzemeier; Georg Ertl; Theo Pelzer
Journal:  Toxicol Pathol       Date:  2009-12       Impact factor: 1.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.